In vitro assembly of a complete, pentaglycine interpeptide bridge containing cell wall precursor (lipid II-Gly5) of Staphylococcus aureus.
about
Thioridazine induces major changes in global gene expression and cell wall composition in methicillin-resistant Staphylococcus aureus USA300Bacterial GCN5-Related N-Acetyltransferases: From Resistance to RegulationActivities and regulation of peptidoglycan synthasesMolecular features of the sortase enzyme familyEurocin, a New Fungal Defensin: STRUCTURE, LIPID BINDING, AND ITS MODE OF ACTIONSpecificity Determinants for Lysine Incorporation in Staphylococcus aureus Peptidoglycan as Revealed by the Structure of a MurE Enzyme Ternary ComplexThe Lantibiotic NAI-107 Binds to Bactoprenol-bound Cell Wall Precursors and Impairs Membrane FunctionsType AII lantibiotic bovicin HJ50 with a rare disulfide bond: structure, structure-activity relationships and mode of actionPreparative scale cell-free production and quality optimization of MraY homologues in different expression modesIdentification and in vitro analysis of the GatD/MurT enzyme-complex catalyzing lipid II amidation in Staphylococcus aureusThe nonantibiotic small molecule cyslabdan enhances the potency of β-lactams against MRSA by inhibiting pentaglycine interpeptide bridge synthesisLiving with an imperfect cell wall: compensation of femAB inactivation in Staphylococcus aureus.Kinetic characterization of the glycosyltransferase module of Staphylococcus aureus PBP2.tRNAs as regulators of biological processesHost-guest chemistry of the peptidoglycanCopsin, a novel peptide-based fungal antibiotic interfering with the peptidoglycan synthesis.Structural variations of the cell wall precursor lipid II and their influence on binding and activity of the lipoglycopeptide antibiotic oritavancin.Cross-linked peptidoglycan mediates lysostaphin binding to the cell wall envelope of Staphylococcus aureus.Transcriptomic and functional analysis of an autolysis-deficient, teicoplanin-resistant derivative of methicillin-resistant Staphylococcus aureus.Staphylococcus aureus mutants with increased lysostaphin resistance.Correlation of daptomycin resistance in a clinical Staphylococcus aureus strain with increased cell wall teichoic acid production and D-alanylation.Tripropeptin C blocks the lipid cycle of cell wall biosynthesis by complex formation with undecaprenyl pyrophosphate.The lantibiotic nisin induces lipid II aggregation, causing membrane instability and vesicle budding.Metabolic and trophic interactions modulate methane production by Arctic peat microbiota in response to warming.Bacterial transfer RNAs.A glyS T-box riboswitch with species-specific structural features responding to both proteinogenic and nonproteinogenic tRNAGly isoacceptors.Lipid intermediates in the biosynthesis of bacterial peptidoglycanIdiosyncratic features in tRNAs participating in bacterial cell wall synthesis.Lipid Requirements for the Enzymatic Activity of MraY Translocases and in Vitro Reconstitution of the Lipid II Synthesis PathwayUniformity of glycyl bridge lengths in the mature cell walls of fem mutants of methicillin-resistant Staphylococcus aureusThe biosynthesis of peptidoglycan lipid-linked intermediates.Evolution of peptidoglycan biosynthesis under the selective pressure of antibiotics in Gram-positive bacteria.Direction of aminoacylated transfer RNAs into antibiotic synthesis and peptidoglycan-mediated antibiotic resistanceResponse of Staphylococcus aureus to subinhibitory concentrations of a sequence-selective, DNA minor groove cross-linking pyrrolobenzodiazepine dimer.Antimicrobial nucleoside antibiotics targeting cell wall assembly: recent advances in structure-function studies and nucleoside biosynthesis.Small cationic antimicrobial peptides delocalize peripheral membrane proteins.Roles of tRNA in cell wall biosynthesis.Inhibitors targeting on cell wall biosynthesis pathway of MRSA.The role of the novel Fem protein VanK in vancomycin resistance in Streptomyces coelicolor.Antibiotic Effects on Methicillin-Resistant Staphylococcus aureus Cytoplasmic Peptidoglycan Intermediate Levels and Evidence for Potential Metabolite Level Regulatory Loops.
P2860
Q21133515-F887B6B7-FE44-4ED8-9D8F-2FBC7C0C98EEQ26773344-ABECAA7F-3377-4C00-B1DE-EC9C3D176F94Q26786994-8F4B4A95-5014-4A01-9950-9260B9500FFBQ26864480-DEC86504-8E67-46AF-8A4C-BFE0FFE8371DQ27674703-531AEA3C-A92B-4217-AE9E-D50EA449CEFEQ27680042-1EEC01CF-746E-4352-8B5D-386B5402BA53Q27682197-5D631612-AB0A-4C05-81FA-9A338032E19EQ27690184-E5F578AB-1BD3-41C6-85DB-D8692FA40120Q28248729-A27E4E5D-C788-470B-A97D-1E83756037C3Q28480400-EEA7A84A-AE3D-410C-B46C-CF7002DDA2F4Q28484891-3CEE7E50-70A2-4D34-9831-B16C3F55C4DAQ33296902-F0237019-9F4B-4AD7-B3F4-230D15D601CBQ33714592-E7551C96-6783-4E79-9FAD-E53A8EF47F02Q33737299-B682B23E-373B-47BE-BD0C-5A7AF4EBBF85Q34013593-218CFF16-508C-458E-88AE-F562FE5579EFQ34444715-8E8262FD-7AA8-451F-8F2D-5B1326A87023Q34448260-9F0FECCC-2350-4218-8BE7-EE315C1C55AAQ34514398-17E7FDE7-7BF7-46A9-A719-A4042A5515ECQ35023285-FC207760-A1B1-40C6-916C-27D6B41AA843Q35075303-68E51E7E-E7BC-487E-B8D3-FCB89277DA8CQ35139449-616F7045-A394-4C16-9D24-015E6DBB9ED9Q35139509-23C130EF-D0EB-449F-B56F-7B174811445BQ35222127-3B9A84AF-5E7D-4001-A385-96F2480271F4Q35616264-7005CE17-1059-4A18-A6DE-4CE6035C5D95Q35974736-AE417BB0-ABB0-46D0-B318-2436104D7F37Q36072316-D8635C7B-6BA5-4546-B9F9-4BCCC2906059Q36314747-2A9C28F7-9A57-4FA5-AB86-268E210E68A3Q36328895-0EBFD61D-154C-46CD-8DCA-F95089594C9DQ36518393-47CEC75C-C979-4ACA-845D-AC8CB45719E9Q36760561-9D38C402-97A5-4CF8-A9BF-B9B562764DFFQ37032866-7F2DECC7-3B69-4BC0-88DF-45220C324982Q37081713-40E4A5AF-0E9D-4951-B696-755639585F8AQ37207046-CFDF9290-E587-4AF8-86C4-9C155807A8D3Q37394327-759C37E3-AFB4-4E8A-9AAF-50F86D099D5BQ37683527-58766FEA-8617-4EF9-BD37-5E913A1CA1B8Q37702026-F6765F26-28C7-49D8-8512-964DB6B0DCDFQ37977400-10565EE2-8496-4940-AC2B-AADE71F52FF0Q38035171-6CCF1B6C-A414-4E9B-A2D6-D10ABC6D04BDQ38332457-0136DBB3-D4F8-4555-AF31-3ABADF791D9DQ38892608-36EF9B35-9FAA-43BF-BA5B-E6F2C9F579B8
P2860
In vitro assembly of a complete, pentaglycine interpeptide bridge containing cell wall precursor (lipid II-Gly5) of Staphylococcus aureus.
description
2004 nî lūn-bûn
@nan
2004 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
In vitro assembly of a complet ...... ly5) of Staphylococcus aureus.
@ast
In vitro assembly of a complet ...... ly5) of Staphylococcus aureus.
@en
In vitro assembly of a complet ...... ly5) of Staphylococcus aureus.
@nl
type
label
In vitro assembly of a complet ...... ly5) of Staphylococcus aureus.
@ast
In vitro assembly of a complet ...... ly5) of Staphylococcus aureus.
@en
In vitro assembly of a complet ...... ly5) of Staphylococcus aureus.
@nl
prefLabel
In vitro assembly of a complet ...... ly5) of Staphylococcus aureus.
@ast
In vitro assembly of a complet ...... ly5) of Staphylococcus aureus.
@en
In vitro assembly of a complet ...... ly5) of Staphylococcus aureus.
@nl
P2093
P2860
P921
P1476
In vitro assembly of a complet ...... ly5) of Staphylococcus aureus.
@en
P2093
Alessandro Tossi
Brigitte Berger-Bächi
Hans-Georg Sahl
Imke Wiedemann
Maria Magdalena Senn
P2860
P304
P356
10.1111/J.1365-2958.2004.04149.X
P407
P577
2004-07-01T00:00:00Z